Condition
Coronary Artery Disease Without Residual Ischemia
Total Trials
1
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Amiodarone
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 1 trials
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Phase 3 (1)
Trial Status
Recruiting1
Clinical Trials (1)
Research Network
Common Treatments
- Amiodarone1
- Flecainide1
Active Sponsors
- Win Medica1
- Hippocration General Hospital1
- Pharmassist Ltd1
Related Conditions
- Cardioversion Of Paroxysmal Atrial Fibrillation In The Emergency Department In Patients With Coronary Artery Disease Without Residual Ischemia And An Left Ventricular Ejection Fraction 351
- Atrial Fibrillation Paroxysmal1